CorMedix Inc. financial data

Symbol
CRMD on Nasdaq
Industry
Pharmaceutical Preparations
Location
300 Connell Drive, Suite 4200, Berkeley Heights, NJ
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 25, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 417 % -53.6%
Quick Ratio 28.2 %
Debt-to-equity 30.1 % +131%
Return On Equity -29 % +59.9%
Return On Assets -22.3 % +65.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 65.2M shares +18.6%
Common Stock, Shares, Outstanding 64.4M shares +17.2%
Entity Public Float 237M USD +31.6%
Common Stock, Value, Issued 64.4K USD +17.2%
Weighted Average Number of Shares Outstanding, Basic 58.9M shares +15.7%
Weighted Average Number of Shares Outstanding, Diluted 58.9M shares +15.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 11.5M USD
Cost of Revenue 3.19M USD
Research and Development Expense 3.94M USD -70%
Selling and Marketing Expense 6.75M USD +66.3%
General and Administrative Expense 6.58M USD +75.7%
Operating Income (Loss) -22.4M USD +54.3%
Nonoperating Income (Expense) 511K USD -29.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -19.3M USD +58.3%
Income Tax Expense (Benefit) -1.39M USD
Net Income (Loss) Attributable to Parent -17.9M USD +61.3%
Earnings Per Share, Basic -0.3 USD/shares +67%
Earnings Per Share, Diluted -0.3 USD/shares +67%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 40.7M USD -6.86%
Accounts Receivable, after Allowance for Credit Loss, Current 17.4M USD
Inventory, Net 7.6M USD +261%
Assets, Current 115M USD +44.2%
Property, Plant and Equipment, Net 1.83M USD -2.05%
Operating Lease, Right-of-Use Asset 493K USD -23.1%
Intangible Assets, Net (Excluding Goodwill) 1.84M USD
Assets 119M USD +44.8%
Accounts Payable, Current 1.72M USD -59.8%
Accrued Liabilities, Current 32M USD +358%
Liabilities, Current 33.8M USD +197%
Operating Lease, Liability, Noncurrent 349K USD -32.5%
Liabilities 34.2M USD +187%
Accumulated Other Comprehensive Income (Loss), Net of Tax 90.6K USD -3.68%
Retained Earnings (Accumulated Deficit) -340M USD -5.57%
Stockholders' Equity Attributable to Parent 84.7M USD +20.7%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 53.9M USD -9.92%
Liabilities and Equity 119M USD +44.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -17.3M USD -66.5%
Net Cash Provided by (Used in) Financing Activities -97.1K USD -101%
Net Cash Provided by (Used in) Investing Activities 8.94M USD
Common Stock, Shares Authorized 160M shares 0%
Common Stock, Shares, Issued 64.4M shares +17.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -8.46M USD +52.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 40.8M USD -7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 9.84K USD +12.1%
Deferred Tax Assets, Valuation Allowance 69.2M USD -2.27%
Deferred Tax Assets, Gross 69.2M USD -2.27%
Operating Lease, Liability 517K USD -22.6%
Depreciation 21.8K USD +29.4%
Payments to Acquire Property, Plant, and Equipment 61.3K USD +315%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -17.9M USD +61.3%
Lessee, Operating Lease, Liability, to be Paid 588K USD -25.9%
Property, Plant and Equipment, Gross 1.87M USD +15.9%
Operating Lease, Liability, Current 168K USD +11.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 211K USD +1.44%
Lessee, Operating Lease, Liability, to be Paid, Year One 208K USD +1.46%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 71K USD -43.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 169K USD -19.9%
Preferred Stock, Shares Issued 137K shares -24.8%
Preferred Stock, Shares Authorized 2M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 169K USD
Operating Lease, Payments 205K USD +1.99%
Additional Paid in Capital 424M USD +8.28%
Preferred Stock, Shares Outstanding 137K shares -24.8%
Share-based Payment Arrangement, Expense 68K USD +36%
Interest Expense 36.1K USD +12.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%